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Introduction 
Oral ingestion has long been the most convenient and 
commonly employed route of drug delivery due to its 
ease  of  administration,  least  aseptic  constraints  and 
flexibility in the design of the dosage form. It is well 
known that  modified  release dosage  forms  may  offer 
one  or  more  advantages  over  immediate  release 
formulations of the same drug. There are many ways to 
design  modified  release  dosage  forms  for  oral 
administration;  from  film  coated  pellets,  tablets  or 
capsules  to  more  sophisticated  and  complicated 
delivery  systems  such  as  osmotically  driven  systems, 
systems  controlled  by  ion  exchange  mechanism, 
systems  using  three  dimensional  printing  technology 
and systems using electrostatic deposition technology. 
The design of modified release drug product is usually 
intended  to  optimize  a  therapeutic  regimen  by 
providing slow  and  continuous delivery  of  drug  over 
the entire dosing interval whilst also providing greater 
patient compliance and convenience.
1 
MET, GLZ and PIO are active principles widely used 
and  frequently  combined  in  pharmaceutical 
preparation. All these three drugs are complimentary to 
each other. GLZ being an insulin secretagogue helps in 
insulin  secretion  from  pancreas
2  whereas;  insulin 
secreted under GLZ influence can be utilized by MET 
for its action. MET not only utilizes the insulin secreted 
under  gliclazide  influence  but  also  converts  from 
peripheral tissues.
3 Drawbacks associated with GLZ are 
weight  gain  and  hypoglycemia.
4  This  can  easily  be 
overcome by MET. PIO on the other hand is basically 
responsible  for  eliminating  the  problem  of  insulin 
resistance  occurred  on  long  term  uses  of  sulphonyl 
ureas.
5 
For  the  treatment  of  diabetes  mellitus  the  usual 
combination of drugs which are available in the market 
consists of MET and PIO and/or glipizide, or MET and 
GLZ but all the three drugs are not available in a single 
formulation.  This  addition  seems  to  be  aimed  at 
improving the antidiabetic efficacy. 
Pharmaceutical  processing  and  formulation  often 
introduce  various  interferants  (chemicals  other  than 
drug/s  under  investigation)  into  the  system.  When 
performing quantification these interferants can disturb 
univariate  analysis,  but  with  multivariate  analysis  the 
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Purpose: In this work a numerical method, based on the use of spectrophotometric data 
coupled  to  partial  least  squares  (PLS)  regression  and  net  analyte  preprocessing 
combined with classical least square (NAP/CLS) multivariate calibration, is reported for 
the simultaneous determination of metformin hydrochloride (MET), gliclazide (GLZ) 
and pioglitazone hydrochloride (PIO) in synthetic samples and combined commercial 
tablets. Methods: Spectra of MET, GLZ and PIO were recorded at concentrations within 
their linear ranges (5-25 µg/ml, 0.5-8 µg/ml and 0.5-3 µg/ml respectively) and were 
used  to  compute  a  total  of  25  synthetic  mixtures  involving  15  calibration  and  10 
validation  sets  between  wavelength  range  of  200  and  400  nm  in  0.1N  HCl.  The 
suitability of the models was decided on the basis of root mean square error (RMSE) 
values of calibration and validation data. Results: The analytical performances of these 
chemometric  methods  were  characterized  by  relative  prediction  errors  and  recovery 
studies (%) and were compared with each other. These two methods were successfully 
applied to pharmaceutical formulation, tablet, with no interference with excipients as 
indicated by the recovery study results. Mean recoveries of the commercial formulation 
set  together  with  the  figures  of  merit  (calibration  sensitivity,  selectivity,  limit  of 
detection,  limit  of  quantification  etc.)  were  estimated.  Conclusion:  The  proposed 
methods are simple, rapid and can be easily used as an alternative analysis tool in the 
quality control of drugs and formulation. 
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quantification  can  still  be  performed.  Several 
multivariate  techniques  of  data  analysis  have  been 
developed and used in the chemometric community by 
the  researchers,  out  of  which  PLS  and  NAP/CLS 
methods  are  one  of  them.
6  PLS  regression  is  a 
supervised multivariate method with which quantitative 
analysis of multiple solid forms can be performed even 
if the differences between the spectra are minor.
7 The 
method involves a calibration step in which the relation 
between  spectra  and  component  concentrations  is 
estimated  from  a  set  of  reference  samples,  and  a 
prediction step in which the results of the calibration 
are used to estimate the component concentrations in an 
unknown  sample  spectrum.
8  NAP/CLS  is  one  of  the 
methods under net analyte signal preprocessing (NAS). 
The  NAS  is  the  part  of  the  signal  which  is  directly 
related to the concentration predicted by the calibration 
model.  In  mathematical  terms,  it  is  the  part  of  a 
spectrum which is orthogonal to the space spanned by 
the spectra of all analytes except one.
9 
 
Materials and Methods  
Instrument, reagents and softwares 
Elico  SL  191  double  beam  UV-Visible 
Spectrophotometer, with 1 cm path length was used for 
the  absorbance  measurement.  All  the  chemicals  used 
were of analytical grade. Pure MET was obtained from 
Abhilasha  Pharma  Pvt.  Ltd.,  Gujarat,  GLZ  was 
obtained from Kwality Pharmaceuticals, Amritsar and 
PIO from GMH Laboratories, Baddi.  
The design expert 8.0.4 software and Matlab 7.5 with 
MVC1  toolbox  were  used  for  construction  of  binary 
mixtures and the statistical treatment of the data along 
application of various multivariate methods.  
 
Preparation of standards 
1mg/ml  MET,  GLZ  and  PIO  stock  solutions  were 
prepared by dissolving accurately weighed amounts of 
finely  powdered  pure  MET,  GLZ  and  PIO  in  small 
quantity of methanol and the final volumes were made 
respectively with 0.1N  HCl. Suitably diluted  samples 
from each stock were utilized for max determination of 
individual component followed by serial dilution with 
0.1N HCl to obtain the aliquots falling in linearity.   
 
Standard solutions for multivariate calibration 
The calibration and validation mixtures were prepared 
by mixing MET, GLZ and PIO solutions in different 
ratios varying in their individual linearity ranges viz. 0-
25 µg/ml, 0-8 µg/ml, 0-3 µg/ml. The concentrations of 
combinations  were  decided  by  design  expert  8.0.4 
software under central composite design. Total 25 sets 
were  prepared  out  of  which  15  sets  (Table  1)  were 
utilized as calibration set whereas, the rest 10 served as 
validation sets (Table 2). All the mixtures were scanned 
at  220-299  nm  range  digitized  at  every  3  nm.  The 
absorbance below 220 nm and above 299 nm was not 
taken under consideration due to too much of noise and 
diminished responses respectively. 
Table 1. Calibration set composition 
Runs  MET (µg/ml)  GLZ (µg/ml)  PIO (µg/ml) 
C1  5  1  1 
C2  25  6  0.75 
C3  25  1  3 
C4  5  6  3 
C5  0  3.5  2 
C6  25  3.5  2 
C7  15  3  2 
C8  15  6  2 
C9  15  3.5  0 
C10  15  3.5  3 
C11  16  4  1 
C12  19  0  1 
C13  20  8  1 
C14  20  4  1 
C15  18.5  2  1.6 
 
Table 2. Validation set composition 
Runs  MET (µg/ml)  GLZ (µg/ml)  PIO (µg/ml) 
V1  25  0  1.3 
V2  4.5  2  1.5 
V3  6  0.5  3 
V4  25  7  2.5 
V5  13  6  3 
V6  10  8  0.5 
V7  25  8  3 
V8  5  8  3 
V9  16  4  2 
V10  10  6  1 
 
 
Sample preparation 
Commercial  tablets  of  MET,  GLZ  and  PIO  were 
analyzed for accuracy. The tablets were processed by 
taking at least 10 tablets for each and finely crushed to 
powder  in  separate  mortar-pestles.  An  equivalent 
amount  of  the  obtained  powder  of  each  drug  was 
weighed, dissolved in methanol, sonicated for 20 min, 
made  up  the  volume  with  0.1N  HCl  and  filtered 
through  a  0.5  µm  membrane  filter.  The  final 
concentrations and analyte ratios in each test solution 
lied within the corresponding calibration ranges. Each 
sample  solution  was  prepared  in  triplicate  and 
measured in random order. 
 
Theory  
PLS-1: To  start  working on  PLS-1  using  MATLAB, 
first a data matrix X and a concentration vector Y need 
to be identify against J sensors and I samples. Both X 
and Y is required for the calculation of singular value 
decomposition (SVD). On performing PLSSVD on  X 
and Y matrix, the result will be further 3 matrixes i.e. 
the singular value matrix (S), the right singular value 
matrix (V), and the left singular value matrix (U).  V 
matrix  can  also  be  termed  as  loading  matrix  which 
helps in the determination of score matrix (T), using the 
following equation: 
X× ? = ?              Eq.1  
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Reconstruction of original data matrix X is computed 
by using the preselected numbers of factors as: 
? ???𝑖𝑚????   = ? × ?                   Eq.2 
The predicted value of y can be stated as: 
?(???𝑖𝑚???? ) = ?(???𝑖𝑚???? )  × ?         Eq. 3 
Where, b is regression vector.
10 
Before  finalizing  the  calibration  data,  to  avoid  over 
fitting,  the  optimum  number  of  latent  variables  or 
factors (A) (figure1) should be selected by applying the 
cross validation method, leaving one sample at a time.
11 
 
 
Figure 1. Plot of RMS(CV) vs factor number for calibration set prediction using cross validation of (a) MET PLS-1, (b) MET NAP/CLS, (c) 
GLZ PLS-1, (d) GLZ NAP/CLS, (e) PIO PLS-1, (f) PIO NAP/CLS 
 
NAP/CLS
12:
 In contrast to PLS-1, the concept of NAS 
based calibration utilizes the contribution of two types 
of analyte signals, Yki.e. the analyte of interest and Y-k, 
signals developed by sources of variability. The virtual 
signals  obtained  are  a  sum  of  these  two  and  can  be 
presented as:
 
? = ? 𝑘 + ? −𝑘                        Eq.4 
For  unit  concentration  of  k  the  J×1  vector  can  be 
denoted as skhence 
? = ?𝑘?𝑘 + ? −𝑘                        Eq.5 
Both  sides  of  equations  when  multiplied  with  an 
appropriate  filtering  or  preprocessing  J×J  matrix, 
named,  MNAP  which  in  turn  is  supposed  to  be 
orthogonal to Y-k,the eq.5 get converted to: 
???𝐴𝑃 = ?𝑘?𝑘??𝐴𝑃           Eq.6 
Eq.6 can also be presented as:    
?$ = ?𝑘 ?𝑘
$ 

                        Eq. 7 
Where, Y
$ is matrix of net analyte calibration spectra 
and ?𝑘
$ is net sensitivity for analyte k. 
The  filtering  matrix  in  eq.6  as  mentioned  above  is 
orthogonal to Yk and can be calculated as 
??𝐴𝑃 = ? − (? −𝑘)𝑝? −𝑘           Eq. 8 
Where, L is J×J unitary matrix and (Y-k) 
p is pseudo-
inverse of Y-k. Pseudo-inverse of Y-k can be calculated 
by  applying  singular  value  decomposition  (SVD)  at 
factor A: 
??𝐴𝑃 = [? − ?? ]         Eq. 9 
The applied filter MNAP removes all sources of 
variability except k. The new generated problem can be 
resolved by applying classical least square (CLS) 
method in combination with NAS and that leads to the 
generation of equation 10. 
?𝑘
$ = (? 𝑘
$)?𝑘(?𝑘
 ?𝑘)−1         Eq.10 
Hence unknown concentration xk is determined by: 
?𝑘 = (?𝑘
$
??
$)−1??
$ 
?𝑘
$         Eq.11 
The usual statistical parameters giving an indication of 
the quality of fit of all data are the root mean square 
difference (RMSECV), square of the correlation 
coefficient (R
2) and relative error of prediction 
(REP%). The expressions of these parameters are: 
???𝐸𝐶? =  
1
𝑚    ???? − ?𝑝???  
2 𝑚
1  
1/2
       Eq. 12 
?2=1-
   ???? −?𝑝???  
2 𝑚
1
   ???? −? 2 𝑚
1
                                    Eq.13 
REP%=
100
?  
1
𝑚    ???? − ?𝑝???  
2 𝑚
1  
1/2
           Eq.14 
Bias= 
1
𝑚    ???? − ?𝑝???   𝑚
1                                  Eq.15 
Where  cact  and  cpred  are  the  actual  and  predicted 
concentrations  during  the  cross  validation  process,  m  is 
number of samples used in cross validation and validation.
7 
The goodness of data fit can be visualized in figure 2.  
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Figure 2. Plots of actual vs predicted values for (a) MET PLS-1, (b) MET NAP/CLS, (c) GLZ PLS-1, (d) GLZ NAP/CLS, (e) PIO PLS-1, 
(f) PIO NAP/CLS 
 
Along with the above said statistical formulae, another 
preferred method for assessing the relative accuracy of 
the studied models is the linear regression analysis of 
actual verses predicted data by comparing the results of 
the estimated slope and intercept with their ideal value 
of  1  and  0.  If  the  point  (1,  0)  is  inside  the  EJCR 
(elliptical joint confidence region) for cross validation 
data, it can be concluded that constant and proportional 
bias are absent (figure 3). 
 
 
Figure 3. Ellipticle joint confident region for slope and intercept corresponding to regressions of the actual vs predicted concentrations of 
(a) MET PLS-1, (b) MET NAP/CLS, (c) GLZ PLS-1, (d) GLZ NAP/CLS, (e) PIO PLS-1, (f) PIO NAP/CLS 
 
Results and Discussion 
UV-Vis spectra of MET, GLZ, PIO and mixture 
Figure  4  shows  the  individual  absorption  spectra  of 
MET, GLZ and PIO along with their mixture in 0.1N 
HCl between 200 and 300 nm. 
 
 
PLS-1 and NAP/CLS Results 
The statistical parameters obtained after applying PLS-
1 and NAP/CLS to the spectrophotometric data of cross 
validation  and  validation  are  shown  in  Table  3.  The 
results suggest that the present method is accurate in 
concern to the validation samples, as suggested by the 
low RMSE and REP value for this validation set.  
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Figure 4. Overlay of MET, GLZ, PIO and Mixture. 
 
Analysis of commercial sample 
Commercial mixture products were analyzed using the 
proposed  spectrophotometric  methods.  Results  are 
summarized  in  Table  4.  As  can  be  seen,  satisfactory 
results were obtained by the proposed methods. 
 
Conclusion 
A  comparative  study  with  the  use  of  PLS-1  and 
NAP/CLS  for  the  separation  and  simultaneous 
estimation of MET, GLZ and PIO in a binary mixture 
has  been  accomplished,  showing  that  this 
spectrophotometric method provides a good example of 
the high resolving power of these techniques. In other 
words,  almost  comparable  results  were  obtained  for 
these  three  drugs  in  both  synthetic  and  commercial 
mixture. The results obtained confirm the suitability of 
the  proposed  method  for  accurate  analysis  of  MET, 
GLZ  and  PIO  in  pharmaceutical  preparations.  These 
methods  were  applied  directly  to  the  commercial 
mixture  preparations  without  previous  treatment.  In 
addition  the  proposed  methods  are  suitable  for 
application without interference of the excipients as well. 
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Table 3. Statistical parameters for the optimized models 
Parameters 
  MET  GLZ  PIO 
  PLS-1  NAP/CLS  PLS-1  NAP/CLS  PLS-1  NAP/CLS 
Calibration set results 
No. of factors  6  6  9  11  8  10 
Press  0.6673  0.4725  0.0502  0.1022  0.0087  0.0273 
RMSE(µg/ml)  0.2110  0.1776  0.0579  0.0826  0.0241  0.0427 
REP%  1.3271  1.1172  1.5817  2.2535  1.4876  2.6345 
Slope  0.9996  1.0003  1.0000  1.0006  0.9987  0.9988 
R
2  0.9991  0.9994  0.9992  0.9984  0.9992  0.9976 
Bias  0.0000  0.0000  0.0000  0.0000  0.0000  0.0000 
Validation set results 
Press  0.5330  0.4973  0.1179  0.2057  0.0455  0.0904 
RMSE(µg/ml)  0.2309  0.2230  0.1086  0.1434  0.0674  0.0951 
REP%  1.6549  1.5986  2.1939  2.8977  3.2416  4.5721 
Slope  1.0010  1.0089  1.0018  1.0101  1.0193  0.9847 
R
2   0.9993  0.9993  0.9988  0.9979  0.9954  0.9884 
Bias  0.0677  0.0137  -0.0186  0.0141  0.0112  0.0121 
Figure of merits 
LOD(µg/ml)  0.1861  0.1564  0.0510  0.0727  0.0213  0.0377 
LOQ(µg/ml)  0.5639  0.4741  0.1546  0.2205  0.0646  0.1142 
SEM  0.0563  0.0474  0.0154  0.0221  0.0064  0.0114 
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Table 4. Prediction results on recovery samples 
Commercial Sample (nominal content) 
Metformin HCl
*  Gliclazide
*  Pioglitazone HCl
* 
PLS-1  NAP/CLS  PLS-1  NAP/CLS  PLS-I  NAP/CLS 
MET-500mg, GLZ-30mg, PIO-15mg 
500.33 (2.08) 
(100.06%) 
501.33 (2.08) 
(100.26%) 
30.33 (2.08) 
(101.11%) 
29.00 (1.00) 
(96.66%) 
14.33 (2.08) 
(95.55%) 
16.66 (1.52) 
(111.11%) 
MET-500mg, GLZ-30mg, PIO-45mg 
500.33 (2.51) 
(100.06%) 
496.66 (1.15) 
(99.33%) 
31.00 (2.00) 
(103.33%) 
29.33 (2.51) 
(97.77%) 
45.33 (2.08) 
(100.74%) 
45.00 (2.00) 
(100.00%) 
MET-500mg, GLZ-80mg, PIO-15mg 
496.66 (1.52) 
(99.33%) 
500.00 (2.00) 
(100.00%) 
79.00 (2.00) 
(98.75%) 
82.66 (1.52) 
(103.33%) 
15.00 (2.00) 
(100.00%) 
14.33 (1.54) 
(95.55%) 
MET-500mg, GLZ-80mg, PIO-45mg 
498.66 (3.05) 
(99.73%) 
498.33 (1.52) 
(99.66%) 
82.00 (1.00) 
(102.50%) 
79.33 (1.52) 
(99.19%) 
46.00 (1.73) 
(102.22%) 
44.33 (1.53) 
(98.51%) 
*The results are averages of three replicates and are given in mg per sample. ±S.D. is in parenthesis. 
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